Key Takeaways Nightingale Health's innovative disease detection from a single blood sample and international deals could boost global market penetration and revenue expansion. Strategic vertical integration, low burn rate, and possible stock listings aim to enhance operational efficiency, financial stability, and investor interest.Read more
Catalysts About Nightingale Health Oyj Nightingale Health Oyj provides blood based molecular profiling and risk assessment tools for prevention focused health care and medical research. What are the underlying business or industry changes driving this perspective?Read more
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
